At 2mL in a 5mg vial, the maximum 2.4mg dose is 96 units within the 100-unit syringe
Semaglutide is shown to help reduce appetite, which can be beneficial for those who struggle with overeating or frequent food cravings
When combined, patients may experience: Markedly reduced food intake, potentially leading to inadequate nutrition Difficulty consuming sufficient calories to maintain healthy body function Increased risk of nutrient deficiencies if dietary intake becomes severely restricted Challenges in maintaining adequate hydration Cardiovascular considerations also warrant attention
Confirm the concentration reads 5mg/ml
Tesamorelin 10mg Summary Description: Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH), developed for the reduction of excess abdominal fat in HIV-associated lipodystrophy
A growing number of researchers use sub-therapeutic doses of semaglutide, sometimes called microdosing, for specific goals that do not require the full 2.4mg maintenance dose
